AdvancedTools in HPLC methoddevelopment

Similar documents
Technical Overview. Author. Abstract. Edgar Naegele Agilent Technologies, Inc. Waldbronn, Germany

Peptide Mapping: A Quality by Design (QbD) Approach

Quality-by-Design-Based Method Development Using an Agilent 1290 Infinity II LC

Overview of preparative HPLC. Analytical Technologies Limited

Fast Preparative Column Liquid Chromatography (PCLC)

ADVANCE ACCURACY AND PRODUCTIVITY FOR FASTER ANALYSIS

HPLC to UPLC Method Migration: An Overview of Key Considerations and Available Tools

Combining High Temperature and Small Particles: The Advantages of Zirconia

Analysis and Purification of Polypeptides by Reversed-Phase HPLC

Method Development Considerations for Reversed-Phase Protein Separations

Fast and High-Resolution Reversed-Phase Separation of Synthetic Oligonucleotides

Development of Ultra-fast ph-gradient Ion Exchange Chromatography for the Separation of Monoclonal Antibody Charge Variants

Method Translation in Liquid Chromatography

2012 Waters Corporation 1

Agilent AdvanceBio SEC Columns for Aggregate Analysis: Instrument Compatibility

Developing Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus

Analysis of TCM injections using the Agilent 1290 Infinity LC system

APPLICATIONS TN Overview of Kinetex 2.6 µm Core-Shell Technology

The Theory of HPLC Gradient HPLC

Quick Manual to the Waters UPLC System

Maximizing Chromatographic Resolution of Peptide Maps using UPLC with Tandem Columns

easy. HPLC has never been so Agilent 1120 Compact LC Our measure is your success.

A Fast and Robust Linear ph Gradient Separation Platform for Monoclonal Antibody (MAb) Charge Variant Analysis

Application of Agilent AdvanceBio Desalting-RP Cartridges for LC/MS Analysis of mabs A One- and Two-dimensional LC/MS Study

Development of Analysis Methods for Therapeutic Monoclonal Antibodies Using Innovative Superficially Porous Particle Biocolumns

R R Innovation Way P/N SECKIT-7830 Newark, DE 19711, USA Tel: Fax: Website: Published in November 2013

High Temperature Liquid Chromatography

Preparative HPLC: Factors and Parameters that Directly Affect Recovery of Collected Fractions

Analysis of 16 Pesticide Residues in Broccoli Using CarbonX dspe QuEChERS AOAC Kits Using GC/MS

Genotoxicity is the property of a compound

Optimizing the Purification of a Standard Chiral Compound Utilizing a Benchtop, Multi-Purpose, Semi-Preparative to Preparative HPLC System

Featuring Analyst software under Windows NT for enhanced performance and ease of use. API 150EX. LC/MS System

Bivalirudin Purification:

Chromatography Column Performance and Data Analysis Success Guide. Hints and Tips for Better Purifications

New Core-Shell Technology

Accucore. Ultimate Core Performance LC Column Technology to Maximize Your Investment. Dave Jarzinski. October 2011

Flexibility with. Preparative HPLC

Thermo Scientific Peptide Mapping Workflows. Upgrade Your Maps. Fast, confident and more reliable peptide mapping.

C196-E067A. Prominence UFLCXR. Shimadzu Ultra Fast Liquid Chromatograph

Research Paper Development of Stability Indicating Reverse Phase HPLC Method for Aripiprazole from Solid Dosage form

Preparative, Pilot & Process Columns

Fraction Analysis of Cysteine Linked Antibody-Drug Conjugates Using Hydrophobic Interaction. chromatography. Agilent 1260 Infinity II Bio-Inert System

Promix TM. Enter a New Era in Biomolecule Analysis with. Columns. Unsurpassed Selectivity and Peak Capacity for Peptides and Proteins

MAbPac SCX-10 Columns

Improving Resolution and Column Loading Systematically in Preparative Liquid Chromatography for Isolating a Minor Component from Peppermint Extract

Qualification of High-Performance Liquid Chromatography Systems

Quantification of Drug Metabolites in Early-Stage Drug Discovery Testing

Laboratory Reagents. for life science research.

BÜCHI Labortechnik AG

Concentration of Human Hormones in Drinking Water Using Solid Phase Extraction and Analysis by High Performance Liquid Chromatography

Improved SPE for UPLC/MS Determination of Diquat and Paraquat in Environmental

Fundamentals and Techniques of Preparative HPLC. Parto Zist Behboud Tel: 42108

High Throughput Screening Technologies for developing purification processes of proteins. Michel Eppink, Synthon BV, Nijmegen

Size Exclusion Chromatography of Biosimilar and Innovator Insulin Using the Agilent AdvanceBio SEC column

Fast and Efficient Peptide Mapping of a Monoclonal Antibody (mab): UHPLC Performance with Superficially Porous Particles

SEC-MS with Volatile Buffers for Characterization of Biopharmaceuticals

Disulfide Linkage Analysis of IgG1 using an Agilent 1260 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column

Zwitterion Chromatography ZIC

Measurement of Enzyme Kinetics by UV-Visible Spectroscopy

Agilent 6400 Series Triple Quadrupole LC/MS. Breakthrough sensitivity now routine for your lab

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON ARTEMETHER AND LUMEFANTRINE CAPSULES REVISED DRAFT FOR DISCUSSION

Available Online through (or) IJPBS Volume 2 Issue 3 JULY-SEPT Research Article Pharmaceutical Sciences

EASY-Spray Columns. Guidance for column set up and installation Tips to maximize column lifetime

Purification Workflow Management

Agilent 6430 Triple Quadrupole LC/MS System

QbD approach for analytical method development of anti-pschotic drug

Update to USP <621> Chromatography: What does this mean? USP 37 NF 32 1S Current as of August 2014

HPLC METHODOLOGY MANUAL

An Automated System for At-Line Process Analysis of Biopharmaceutical Fermentation Reactions

Rapid Soft Spot Analysis using the SCIEX Routine Biotransform Solution

Fast mass transfer Fast separations High throughput and improved productivity Long column lifetime Outstanding reproducibility Low carryover

Improved Peptide Maps Using Core-Shell Media: Explaining Better Biopharmaceutical Applications With Kinetex C18 Columns

Phase Appropriate Method Validation

A green HPLC technique with a 100% water mobile phase for detecting imidacloprid and its metabolite 6-chloronicotinic acid

RP-HPLC METHOD FOR QUANTITATIVE ESTIMATION OF GLATIRAMER ACETATE FOR INJECTION IN PHARMACEUTICAL DOSAGE FORMS

Analysis of Intact and C-terminal Digested IgG1 on an Agilent Bio MAb 5 µm Column

Preparative HPLC is still the

ZORBAX StableBond HPLC Columns

Application Note. Author. Abstract. Biotherapeutics and Biologics. Sonja Schneider Agilent Technologies, Inc. Waldbronn, Germany

mabs and ADCs analysis by RP

Pharmaceutical LC/MS Solutions from Agilent Technologies

SIMPLIFY AND ACCELERATE GAS ANALYSIS. Micro GC Fusion GAS ANALYZER

Liquid Chromatograph Liquid Chromatograph Mass Spectrometer. CL Series. for In Vitro Diagnostic Use

Heart-cut 2D-LC/MS approach for pharmaceutical impurity identification using an Agilent 6540 Q-TOF LC/MS System

PERFORMANCE OF VAISALA OZONE INTERFACE BOARD OIF411

Temperature and ph Stability of a New High Temperature C18 Polydentate Silica Column

Superdex 200 Increase columns

Determination of Isoelectric Point (pi) By Whole-Column Detection cief

Characterization of mab aggregation using a Cary 60 UV-Vis Spectrophotometer and the Agilent 1260 Infinity LC system

Application Note. Author. Abstract. Environmental. Edgar Naegele Agilent Technologies, Inc. Waldbronn, Germany

Determination of Adenovirus pviii (31K) Concentration for Estimation of the Empty Capsid Concentration of the Adenovirus Reference Material (ARM)

Determine Phase Appropriate Activities A Lifecycle Approach for Analytical Procedures and Methods Validation

Analytical Methods Development and Validation

Analysis of biomolecules by SEC and Ion-Exchange UPLC

PLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mabs and ADC

Certificate of Analysis

Streamlined Purification of Assay-Ready Oligonucleotides by Automated HPLC

High Resolution Analysis of Heparin and Heparin-like Impurities on Glycomix TM an Anion Exchange Column

Generating Automated and Efficient LC/MS Peptide Mapping Results with the Biopharmaceutical Platform Solution with UNIFI

Transcription:

AdvancedTools in HPLC methoddevelopment Remco Stol, Enrico Martina and Jeffrey Vos Analytical Sciences Chemistry, Quality Unit API/BT NL FHI symposium, Houten, 22 april 2010

What does the customer want? Be able to determine compounds X, Y, Z at levels of Control quality of product Y, sourced from multiple suppliers Identity, assay, impurities (0.05% or trace) Monitor stability Trouble shooting, once-a-time analysis Routine test Cheap Without issues Fast 2

Typical HPLC Method Development Goals Achieve separation selectivity Quantitative Sensitivity Linear Accurate Precise Robust, rugged 3

Typical system failures in routine operation and method development Resolution Retention time Precision Tailing factor, plate number Studied in detail Not studied Not studied Somewhat studied, SST setting 4

Optimization parameters Continuous parameters easy to adjust Solvent strength (% modifier) Temperature Gradient (slope, start- end %) Discontinuous parameters Hard-to-adjust Column type ph Organic solvent Salt concentration, type (buffer, ion pairing) Old way : 1) select discontinuous parameters, test, find optimum, next parameter (OVAT) 2) optimize continuous parameters Strange approach: Most relevant selectivity parameters are of discontinuous type Current way : 1) screen discontinuous parameters (e.g. column & ph scouting) 2) optimize continuous parameters 3) automate where possible Better approach: Most relevant selectivity parameters are of discontinuous type 5

Start screening right Relevant samples Stress & stability samples Samples from different suppliers/sources Solvents Typically ACN and MEOH, others are possible Select set of columns based on chemistry pka, functional groups, Log P Detection principle UV, λ max Other, MS Select buffers MS compatible UV transparent Sample and column stability Peak tracking (minor added value in this phase) MS and/or DAD 6

Discontinuous parameter screening 7

Discontinuous parameter screening Flow: 0.5 ml/min Column temperature: 20ºC Injection volume: 5ul Concentration: 1 mg/ml Detection wavelength: 210 nm Buffers: 100 mm potassium hexafluorophosphate, ph 2 Modifier: acetonitrile Columns: - Chiracel OD-RH - Chiracel AD-RH - Chiracel OJ-RH - Chiracel AS-RH R R R Screening performed with racematic mixture of all four forms (SS, RR, RS and SR) R 8

Discontinuous parameter screening mau 12 10 8 DAD1 A, Sig=210,4 Ref=off, TT (D:\CSADATA\INSTR1\SCH900435-K\DATA\00003582 2010-02-25 12-19-22\00003582.D) 19.685 Area: 242.577 23.592 25.809 Area: 17641.6 Area: 17491 OJ-RH, 38% ACN mau 14 12 10 DAD1 A, Sig=210,4 Ref=off, TT (D:\CSADATA\INSTR1\SCH900435-K\DATA\00003623 2010-02-26 20-47-02\00003623.D) 15.748 24.493 Area: 17639.1 Area: 17667.7 OD-RH, 40% ACN 6 8 18.662 Area: 251.734 4 2 6 4 2 28.150 Area: 257.221 0 0 10 20 30 40 50 min 10 20 30 40 50 min mau DAD1 A, Sig=210,4 Ref=off, TT (D:\CSADATA\INSTR1\SCH900435-K\DATA\00003524 2010-02-23 17-02-29\00003524.D) 7.879 11.988 Area: 17465.3 Area: 17404.1 AS-RH, 42% ACN mau DAD1 A, Sig=210,4 Ref=off, TT (D:\CSADATA\INSTR1\SCH900435-K\DATA\00003545 2010-02-24 07-42-07\00003545.D) 7.949 9.061 Area: 479.09 Area: 34318.3 AD-RH, 37% ACN 25 20 20 7.130 Area: 244.221 15 15 10 10 5 0 9.669 Area: 55.1914 15.441 Area: 18.3398 5 10.883 Area: 73.9407 0-5 5 10 15 20 25 30 min 5 10 15 20 25 30 35 40 min 9

Discontinuous parameter screening mau DAD1 A, Sig=210,4 Ref=off, TT (D:\CSADATA\INSTR1\SCH900435-K\DATA\00003623 2010-02-26 20-47-02\00003623.D) DAD1 A, Sig=210,4 Ref=off, TT (D:\CSADATA\INSTR1\SCH900435-K\DATA\00003625 2010-02-26 22-46-21\00003625.D) DAD1 A, Sig=210,4 Ref=off, TT (D:\CSADATA\INSTR1\SCH900435-K\DATA\00003621 2010-02-26 18-47-41\00003621.D) 14 12 10 8 6 4 45% ACN 40% ACN 35% ACN 2 0 10 20 30 40 50 min Flow: 0.5 ml/min Column temperature: 20ºC Injection volume: 5ul Concentration: 1 mg/ml Detection wavelength: 210 nm Buffers: 100 mm potassium hexafluorophosphate, ph 2 Column: Chiracel OD-RH 10

Evaluation of Scouting data Pick a winner strategy: optimal discontinuous parameters based # of peaks detected, (critical) resolution Use modeling and chemometric techniques to evaluate data Model can be based on retention or trend response Resolution vs temperature Resolution compound x-y vs % modifier Peak area main vs %ACN Peak height second largest peak Typical goal is to exclude conditions not to optimize! Peak tracking is typically not essential (efficient) during scouting 11

Fine-tuning using Design of Experiments (DoE) A two level factorial design (including center points) was used to optimize the separation and estimate robustness. Variables were: Flow rate Amount of modifier Column temperature Buffer concentration responses were: Resolutions Tailing factor Retention time 12

Estimating optimum conditions Software (design expert) calculates the optimum conditions in the region tested. Ranges tested were: Flow rate in range: 0.3 0.7 ml/min. Amount of acetonitrile in range 38% - 42% Column temperature in range 20 40 C Buffer concentration in range 50 150 mm Maximize resolutions Minimize tailing factor and retention time 13

Optimum conditions Flow: 0.5 ml/min Column temperature: 25ºC Buffer concentration: 150 mm potassium hexafluorophosphate, ph 2 Amount acetonitrile: 38% Injection volume: 5 ul Detection wavelength: 210 nm Concentration: 1 mg/ml Column: Chiracel OD-RH 14

Estimating robustness DoE software capable of simulating data Design expert 6 (stat-ease, inc.) Inputs are the regression coefficients from the equation derived during optimization. (i.e. Y = A + B 1 X 1 + B 2 X 2 ) Be carefull, extrapolation of regression models can be prone to errors. 15

Estimating robustness Resolution 27.00 Overlay Plot Rs 2,1: 1.978 26.00 B: column temperature 25.00 6 24.00 Rs 3,2: 1.418 23.00 0.45 0.47 0.50 0.53 0.55 A: flow rate 16

Estimating robustness Peak width and resolution 27.00 Overlay Plot Rs 2,1: 1.978 26.00 B: column temperature 25.00 6 peak width peak 1: 2.298 peak width peak 4: 4.668 24.00 Rs 3,2: 1.418 23.00 0.45 0.47 0.50 0.53 0.55 A: flow rate 17

Estimating robustness Retention time, peak width and resolution 27.00 Overlay Plot Rs 2,1: 1.978 B: column temperature 26.00 25.00 Rt peak 5: 23.67 Rt peak 4: 20.62 Rt peak 2: 14.4 Rt peak 1: 12.72 peak width peak 4: 4.668 peak width peak 1: 2.298 6 Rt peak 2: 17.6 Rt peak 1: 15.54 Rt peak 4: 25.2 Rt peak 5: 28.93 24.00 Rs 3,2: 1.418 23.00 0.45 0.47 0.50 0.53 0.55 A: flow rate 18

Conclusions Automation and smart solutions used throughout method development Discontinuous scouting is fully automated Experimentation is software supported Experiments are programmed by the software 24/7 unattended experimentation The experimental design model is build throughout the fine tuning The model allows not just better method development, it allows robustness to be a real goal during method development. Automation helps to get better (rugged) methods into routine operation 19

Next goals Introduce DoE during scouting Incorporate numerical and categorical variables: Algorithm design, others. Use scouting data for model building Replace formal robustness testing from validation PAR in addition to set-point values in (validated) method descriptions Get acceptance from internal customers Get acceptance from external customers 20